Brief: Evolent Health Q4 Revenue USD 556.055 Million Vs. IBES Estimate USD 542.4 Million
22/02/2024 21:10
Feb 22 (Reuters) - Evolent Health Q4 adjusted EBITDA USD 48.055 million vs. IBES estimate USD 48.5 million. * Q4 adjusted EBITDA margin 8.6% * Q4 net income USD -41.395 million vs. IBES estimate USD 16.8 million * outlook Q1 adjusted EBITDA USD 52-58 million * outlook FY adjusted EBITDA USD 235-265 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows